Cencora Prices $500 Million 5.125% Senior Notes Due 2034
06 February 2024 - 10:18AM
Business Wire
Cencora, Inc. (NYSE: COR) today announced that it priced $500
million aggregate principal amount of its 5.125% Senior Notes due
2034 (the “Notes”), in an underwritten registered public offering.
The offering is being made pursuant to an effective shelf
registration statement Cencora filed with the Securities and
Exchange Commission (the “SEC”) on November 23, 2021. The offering
is expected to close on February 7, 2024, subject to the
satisfaction of customary closing conditions. Cencora intends to
use the net proceeds from the offering to redeem all of its 3.400%
Senior Notes due May 15, 2024 (the “2024 Notes”) with any remaining
net proceeds to be used for general corporate purposes.
The joint book-running managers for the offering are BofA
Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan
Securities LLC and Wells Fargo Securities, LLC. Earlier today,
Cencora filed a preliminary prospectus supplement and an
accompanying prospectus with the SEC in connection with the
offering of the Notes. Copies of these materials can be made
available by contacting: BofA Securities, Inc., NC1-022-02-25, 201
North Tryon Street, Charlotte, North Carolina 28255, Attention:
Prospectus Department, email: dg.prospectus_requests@bofa.com or
telephone: 1-800-294-1322; Citigroup Global Markets Inc., c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood,
New York 11717, email: prospectus@citi.com or telephone:
1-800-831-9146; J.P. Morgan Securities LLC, Attention: Broadridge
Financial Solutions, 1155 Long Island Avenue, Edgewood, New York
11717 or telephone: 1-866-803-9204; or Wells Fargo Securities LLC,
608 2nd Avenue South, Suite 1000, Minneapolis, Minnesota 55402,
Attention: WFS Customer Care (phone: 1-800-645-3571; email:
wfscustomerservice@wellsfargo.com). Electronic copies of the
preliminary prospectus supplement and accompanying prospectus are
also available on the SEC’s Web site at www.sec.gov.
This news release shall not constitute an offer to sell or the
solicitation of an offer to buy the Notes, nor shall there be any
sale of the Notes in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction. In addition, this news release does not constitute a
notice of redemption with respect to the 2024 Notes or an
obligation to issue any such notice of redemption. Any such notice
of redemption, if given, will only be given in accordance with the
terms of the 2024 Notes.
About Cencora
Cencora is a leading global pharmaceutical solutions
organization centered on improving the lives of people and animals
around the world. We partner with pharmaceutical innovators across
the value chain to facilitate and optimize market access to
therapies. Care providers depend on us for the secure, reliable
delivery of pharmaceuticals, healthcare products, and solutions.
Our 46,000+ worldwide team members contribute to positive health
outcomes through the power of our purpose: We are united in our
responsibility to create healthier futures. Cencora is ranked #11
on the Fortune 500 and #24 on the Global Fortune 500 with more than
$250 billion in annual revenue.
Cencora’s Cautionary Note Regarding Forward-Looking
Statements
Certain of the statements contained in this press release are
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the “Securities
Exchange Act”). Words such as “aim,” “anticipate,” “believe,”
“can,” “continue,” “could,”, “estimate,” "expect," “intend,” “may,”
“might,” “on track,” “opportunity,” “plan,” “possible,”
“potential,” “predict,” “project,” “seek,” “should,” “strive,”
“sustain,” “synergy,” “target,” “will,” “would” and similar
expressions are intended to identify forward-looking statements,
but the absence of these words does not mean that a statement is
not forward-looking. These statements are based on management’s
current expectations and are subject to uncertainty and changes in
circumstances and speak only as of the date hereof. These
statements are not guarantees of future performance and are based
on assumptions and estimates that could prove incorrect or could
cause actual results to vary materially from those indicated. A
more detailed discussion of the risks and uncertainties that could
cause our actual results to differ materially from those indicated
is included in the “Risk Factors” and “Management’s Discussion and
Analysis” sections in the Company’s Annual Report on Form 10-K for
the fiscal year ended September, 30, 2023 and elsewhere in that
report and (ii) other reports filed by the Company pursuant to the
Securities Exchange Act. The Company undertakes no obligation to
publicly update or revise any forward-looking statements, except as
required by the federal securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240205856996/en/
Bennett S. Murphy Senior Vice President, Head of Investor
Relations & Treasury 610-727-3693
bennett.murphy@cencora.com
Cencora (NYSE:COR)
Historical Stock Chart
From Apr 2024 to May 2024
Cencora (NYSE:COR)
Historical Stock Chart
From May 2023 to May 2024